The ExoDx Prostate Test provides a risk assessment for finding clinically significant prostate cancer that otherwise relies on biopsy in men with an elevated PSA.

A standalone, exosome-based prostate cancer test delivering a unique data point to help guide the prostate biopsy decision. The ExoDx Prostate Test is included in both the NCCN and AUA …

At Exosome Diagnostics, we provide clarity in this uncertain world by validating the ExoDx Prostate Test in men undergoing screening with PSA levels of 2 to 10 ng/mL to give them better clarity on whether …

The only exosome-based test that provides unique, actionable intelligence to help you decide if biopsy is necessary; independent of PSA and other standard of care (SOC) features.

The ExoDx™ Prostate Test is a simple, non-DRE, urine-based, liquid biopsy test indicated for men 50 years of age and older with a prostate-specific antigen (PSA) 2-10ng/mL, or PSA in the “gray zone” …

Answers about the ExoDx Prostate Test non-invasive urine test for Prostate Cancer. Learn about sensitivity of the EPI test, biomarkers analyzed, and interpretation of results.

Taking Charge of Your Prostate Health The ExoDx Prostate Test – A simple urine test to help inform the prostate biopsy decision.

If you are a patient working with your physician to assess prostate cancer risk, there are two ways to order the ExoDx Prostate Test: At-Home Collection or In-Office Collection.

Learn about prostate cancer, alternative options for detection, and how the ExoDx test can help discriminate between slow-growing and aggressive prostate cancer.

Learn how exosomes function and can be used to assess prostate cancer risk with a non-invasive liquid biopsy procedure & as a prostate cancer detection tool.